Cynata’s Stem Cell Manufacturing Platform to Allow for Scalability of Harvard’s Modified Stem Cells
While methods for treating cancer have improved over the past decade, there remain limited techniques for addressing aggressive cancers, including those that cannot be surgically removed due to location or type. Cancers such as glioblastoma, the most common and aggressive type of brain tumour in adult humans, continue to produce high fatality rates. In addition, chemotherapy remains a widespread technique for killing or stopping cancer progression, despite its extremely harmful side effects. For this reason, cell therapies are now being explored for their potential to act as targeted cancer killing agents. [Read more…]